OUTLOOK THERAPEUTICS, INC. Capital Expenditures
OUTLOOK THERAPEUTICS, INC. (OTLK) reported Capital Expenditures of $437.31 thousand for the 12-month period ending 2019-09-30, per its 10-K filed 2020-12-23.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2020-12-23
- OUTLOOK THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2019-09-30 was $1.00, a 100.00% decline year-over-year.
- OUTLOOK THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2019-06-30 was $150.74K, a 10.29% decline year-over-year.
- OUTLOOK THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2019-03-31 was $50.14K, a 81.78% decline year-over-year.
- OUTLOOK THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2018-12-31 was $236.43K, a 78.01% decline year-over-year.
- OUTLOOK THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2019 was $437.31K, a 84.28% decline from fiscal 2018.
- OUTLOOK THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2018 was $2.78M, a 852.16% increase from fiscal 2017.
- OUTLOOK THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2017 was $292.09K, a 73.40% decline from fiscal 2016.
- OUTLOOK THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2016 was $1.10M, a 87.53% decline from fiscal 2015.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2019-09-30 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-23 | $150.74K derived: sum of 2 quarters · filed 2020-12-23 | $200.87K derived: sum of 3 quarters · filed 2020-12-23 | $437.31K 10-K · filed 2020-12-23 |
| 2019-06-30 | $150.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-14 | $200.87K derived: sum of 2 quarters · filed 2020-08-14 | $437.31K 10-Q · filed 2020-08-14 | $1.70M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $50.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-15 | $286.57K 10-Q · filed 2020-05-15 | $1.55M derived: sum of 3 quarters · filed 2020-05-15 | $1.72M derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $236.43K 10-Q · filed 2020-02-14 | $1.50M derived: sum of 2 quarters · filed 2020-02-14 | $1.67M derived: sum of 3 quarters · filed 2020-02-14 | $1.94M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-09-30 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-19 | $1.43M derived: sum of 2 quarters · filed 2019-12-19 | $1.71M derived: sum of 3 quarters · filed 2019-12-19 | $2.78M 10-K · filed 2019-12-19 |
| 2018-06-30 | $168.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14 | $443.21K derived: sum of 2 quarters · filed 2019-08-14 | $1.52M 10-Q · filed 2019-08-14 | $1.54M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $275.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-15 | $1.35M 10-Q · filed 2019-05-15 | $1.37M derived: sum of 3 quarters · filed 2019-05-15 | $1.45M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $1.08M 10-Q · filed 2019-02-14 | $1.10M derived: sum of 2 quarters · filed 2019-02-14 | $1.18M derived: sum of 3 quarters · filed 2019-02-14 | $1.22M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-09-30 | $23.98K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-18 | $100.21K derived: sum of 2 quarters · filed 2018-12-18 | $143.72K derived: sum of 3 quarters · filed 2018-12-18 | $292.09K 10-K · filed 2018-12-18 |
| 2017-06-30 | $76.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-14 | $119.74K derived: sum of 2 quarters · filed 2018-08-14 | $268.11K 10-Q · filed 2018-08-14 | $596.52K derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $43.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-15 | $191.88K 10-Q · filed 2018-05-15 | $520.29K derived: sum of 3 quarters · filed 2018-05-15 | $972.76K derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $148.36K 10-Q · filed 2018-02-14 | $476.77K derived: sum of 2 quarters · filed 2018-02-14 | $929.25K derived: sum of 3 quarters · filed 2018-02-14 | $882.30K derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-09-30 | $328.41K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-29 | $780.89K derived: sum of 2 quarters · filed 2017-12-29 | $733.94K derived: sum of 3 quarters · filed 2017-12-29 | $1.10M 10-K · filed 2017-12-29 |
| 2016-06-30 | $452.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-14 | $405.53K derived: sum of 2 quarters · filed 2017-08-14 | $769.77K 10-Q · filed 2017-08-14 | $4.06M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | -$46.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-15 | $317.29K 10-Q · filed 2017-05-15 | $3.61M derived: sum of 3 quarters · filed 2017-05-15 | $7.10M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $364.24K 10-Q · filed 2017-02-14 | $3.66M derived: sum of 2 quarters · filed 2017-02-14 | $7.15M derived: sum of 3 quarters · filed 2017-02-14 | |
| 2015-09-30 | $3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-29 | $6.78M derived: sum of 2 quarters · filed 2016-12-29 | $8.80M 10-K · filed 2016-12-29 | |
| 2015-06-30 | $3.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-15 | $5.51M 10-Q · filed 2016-08-15 | ||
| 2015-03-31 | $2.02M 10-Q · filed 2016-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |